Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Amgen Inc. $AMGN Shares Sold by Healthcare of Ontario Pension Plan Trust Fund
Entropy Technologies LP Buys Shares of 9,161 Amgen Inc. $AMGN
Gabelli Funds LLC Sells 2,735 Shares of Amgen Inc. $AMGN
Gabelli Funds LLC Reduces Stake in Amgen Inc. $AMGN
Wealth Alliance LLC Trims Holdings in Amgen Inc. $AMGN - Markets Daily
Hilltop Holdings Inc. Raises Stock Holdings in Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Bought by Hilltop Holdings Inc. - Zolmax
Wealth Alliance LLC Lowers Stock Holdings in Amgen Inc. $AMGN - Stock Observer
Cetera Investment Advisers Increases Stake in Amgen Inc. $AMGN
Public Employees Retirement System of Ohio Grows Position in Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Sold by Oak Associates Ltd. OH
Amgen Inc. $AMGN Shares Bought by Sei Investments Co.
Compound Planning Inc. Increases Stock Holdings in Amgen Inc. $AMGN - Markets Daily
Amgen settles lawsuit for $74 million: Transfer Pricing Report
Dickmeyer Boyce Financial Management Inc. Makes New Investment in Amgen Inc. $AMGN
Dickmeyer Boyce Financial Management Inc. Acquires Shares of 2,888 Amgen Inc. $AMGN - Markets Daily
Compound Planning Inc. Buys 7,818 Shares of Amgen Inc. $AMGN
Sei Investments Co. Boosts Stake in Amgen Inc. $AMGN - Stock Observer
Public Employees Retirement System of Ohio Boosts Stake in Amgen Inc. $AMGN - Daily Political
What Amgen (AMGN)'s Blocked Colorado Enbrel Price Cap Means For Shareholders - Simply Wall St News
Amgen Inc. $AMGN Shares Bought by First Trust Advisors LP - Daily Political
Disease modification in lupus nephritis: towards a pathophysiology-based treatment paradigm
Advancing antibody drug conjugates in gastrointestinal cancers
Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials
Madison Asset Management LLC Grows Holdings in Amgen Inc. $AMGN - Stock Observer
Amgen (AMGN) Clears An Enbrel Overhang, Is The Stock Fully Priced?
Amgen (AMGN) Stock Looks Reasonable On Earnings While Cash Flow Stays Strong
Triad Investment Management Acquires New Stake in Amgen Inc. $AMGN - Daily Political
Amgen Agrees to $74 Million Settlement Over $10.7 Billion Tax Dispute, ETPharma
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial
Amgen Settles Investor Suit Over Tax Liability for $74 Million
Amgen Inc. $AMGN Shares Sold by Jennison Associates LLC
Efficacy of blinatumomab for dermatomyositis/SLE overlap syndrome occurring after allogeneic hematopoietic stem cell transplant performed for acute lymphoblastic leukemia
FY2026 EPS Estimates for Amgen Decreased by Erste Group Bank - Daily Political
Amgen Earnings Preview: What to Expect
Colorado was the first state to cap a drug's price - then a federal court stepped in
KBC Group NV Sells 319,966 Shares of Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Acquired by Dimensional Fund Advisors LP
AlTi Global Inc. Cuts Stock Position in Amgen Inc. $AMGN
FY2026 EPS Estimates for Amgen Lowered by Erste Group Bank
Is the adult EBMT risk score valid and relevant for hematopoietic stem cell transplantation in children acute leukemia?
SEB Asset Management AB Takes Position in Amgen Inc. $AMGN - Markets Daily
Swiss National Bank Buys 105,080 Shares of Amgen Inc. $AMGN
5,891 Shares in Amgen Inc. $AMGN Bought by Independent Financial Group LLC
SEB Asset Management AB Purchases New Position in Amgen Inc. $AMGN - Stock Observer
AIA Group Ltd Grows Stake in Amgen Inc. $AMGN
A transitional big-pharma giant holding a speculative premium driven by obesity hype, masking severe revenue erosion.
Amgen Inc. $AMGN Shares Bought by German American Bancorp Inc. - Zolmax
Modera Wealth Management LLC Sells 4,769 Shares of Amgen Inc. $AMGN
California Public Employees Retirement System Has $693.38 Million Stock Holdings in Amgen Inc. $AMGN - Markets Daily
Amgen Inc. $AMGN Stock Position Lowered by California Public Employees Retirement System
Amgen Inc. $AMGN Holdings Decreased by Bartlett & CO. Wealth Management LLC
John G Ullman & Associates Inc. Sells 6,675 Shares of Amgen Inc. $AMGN - Stock Observer
Atlas Wealth LLC Has $25.50 Million Position in Amgen Inc. $AMGN
Amgen (AMGN) Earnings Buzz Builds, Is The Stock Already Overvalued?
Atlas Wealth LLC Increases Stake in Amgen Inc. $AMGN - Stock Observer
The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?
SteelPeak Wealth LLC Acquires 20,118 Shares of Amgen Inc. $AMGN
Assetmark Inc. Purchases 15,719 Shares of Amgen Inc. $AMGN
Assetmark Inc. Boosts Stake in Amgen Inc. $AMGN - Stock Observer
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia
Wealthfront Advisers LLC Boosts Position in Amgen Inc. $AMGN
D.A. Davidson & CO. Trims Stake in Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Sold by Bank of New York Mellon Corp
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results
Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage
Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models
Research Analysts' Weekly Ratings Changes for Amgen (AMGN) - Stock Observer
New machine learning model improves cholesterol calculation accessibility
Amgen's Tablet Recalls Test Its Quality Controls and Manufacturing Ambitions (AMGN)
Livforsakringsbolaget Skandia Omsesidigt Increases Stake in Amgen Inc. $AMGN - Stock Observer
AMG National Trust Bank Acquires 3,523 Shares of Amgen Inc. $AMGN - Stock Observer
Pfizer Vs. Amgen: Bet That Pfizer's Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen
Bleakley Financial Group LLC Purchases 3,526 Shares of Amgen Inc. $AMGN - Markets Daily
Calamos Advisors LLC Buys 3,648 Shares of Amgen Inc. $AMGN
Amgen Inc. $AMGN Shares Sold by Mattern Capital Management LLC - Daily Political
Amgen (AMGN) Recalls Corlanor And Sensipar Nationwide Over Quality Control Issues
2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down
Cue Biopharma Appoints Dominic Borie As CMO
Guggenheim Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price
Amgen (NASDAQ:AMGN) Price Target Raised to $343.00 - Zolmax
An anti-PMEL antibody−drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial
Amgen Inc. $AMGN Shares Acquired by Ferguson Wellman Capital Management Inc.
Fifth Third Bancorp Boosts Stock Position in Amgen Inc. $AMGN - Markets Daily
Fifth Third Bancorp Acquires 167,835 Shares of Amgen Inc. $AMGN
Castleview Partners LLC Has $2.77 Million Holdings in Amgen Inc. $AMGN - Daily Political
Candriam S.C.A. Raises Holdings in Amgen Inc. $AMGN
Conning Inc. Has $33.85 Million Position in Amgen Inc. $AMGN
Candriam S.C.A. Buys 3,616 Shares of Amgen Inc. $AMGN - Daily Political
First Horizon Corp Boosts Holdings in Amgen Inc. $AMGN
Ibex Wealth Advisors Increases Stake in Amgen Inc. $AMGN
Explaining genetically engineered rodents to a jury-and ultimately beating Amgen
Amgen Inc. (NASDAQ:AMGN) Receives Average Recommendation of "Hold" from Analysts
AMGN: IRS Dispute And Regulatory Setbacks Will Pressure Future Returns
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
